| Literature DB >> 30997148 |
Alen Zabotti1, Georgios Filippou2, Marco Canzoni3, Antonella Adinolfi4, Valentina Picerno5, Greta Carrara6, Peter Balint7, George A Bruyn8, Maria Antonietta D'Agostino9, Nemanja Damjanov10, Andrea Delle Sedie11, Emilio Filippucci12, Maria Luz Gonzalez Fernandez13, Hilde Berner Hammer14, Zunaid Karim15, Peter Mandl16, Ingrid Moller17, Maria Rosario Morales Lozano18, Esperanza Naredo19, Francesco Porta20, Garifallia Sakellariou21, Lene Terslev22, Carlo Alberto Scirè2,6, Annamaria Iagnocco23.
Abstract
Objective: To evaluate the level of agreement on ultrasonographic (US) lesions among highly experienced sonographers as well as the intraobserver and interobserver reliability of inflammatory and structural US lesions in patients with osteoarthritis (OA) of the foot.Entities:
Keywords: osteoarthritis; outcomes research; ultrasonography
Mesh:
Year: 2019 PMID: 30997148 PMCID: PMC6443136 DOI: 10.1136/rmdopen-2018-000795
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Elementary lesions in foot osteoarthritis: final results of the Delphi survey
| Elementary lesions in foot osteoarthritis | Agreement (%) |
| Midfoot joints must be assessed separately for structural and inflammatory abnormalities in foot OA | 84.2 |
| I MTP joint must be assessed separately for structural and inflammatory abnormalities in foot OA | 100.0 |
| Joint inflammation and structural changes must be assessed separately in foot OA | 94.7 |
| Joint synovial hypertrophy (with or without Doppler signal) should always be assessed in foot OA | 100.0 |
| Joint effusion should always be assessed in foot OA | 89.5 |
| Synovial hypertrophy can be scored semiquantitatively from 0 to 3 (ie, 0=no; 1=mild; 2=moderate; 3=severe) | 84.2 |
| Doppler can be scored semiquantitatively from 0 to 3 (ie, 0=no; 1=mild; 2=moderate; 3=severe) | 89.5 |
| Synovial hypertrophy can also be scored dichotomously (ie, 0=absent; 1=present) | 78.9 |
| Osteophytes should always be assessed for joint structural changes in foot OA | 100.0 |
| Cartilage damage of the first metatarsal head should always be assessed for joint structural changes in foot OA | 78.9 |
| II to V MTP joints must be assessed separately for structural and inflammatory abnormalities in foot OA | 94.7 |
MTP, metatarsophalangeal; OA, osteoarthritis.
Intraobserver and interobserver results of the static, web-based, exercise considering together results of midfoot and MTP joints (strength of agreement: <0.20 poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, 0.81–1.00 excellent)
| Intraobserver agreement of the static exercise | Interobserver agreement of the static exercise | |||||||||||
| Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean | Prevalence mean | Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean | Kappa mean | PABAK mean | PABAK mean | |
| 61 (40–78) | 83 (51–94) | 0.64 (0.00–0.87) | 0.66 (0.03–0.87) | 59 | 63 | 75 | 83 | 0.50 | 0.64 | 0.51 | 0.66 | |
| 59 (46–73) | 84 (30–100) | 0.67 (−0.39 to 1) | 0.67 (−0.40 to 1) | 63 | 56 | 80 | 80 | 0.80 | 0.61 | 0.61 | 0.61 | |
| 63 (46–79) | 84 (64–100) | 0.64 (0.22–1) | 0.68 (0.29–1) | 66 | 63 | 82 | 83 | 0.60 | 0.63 | 0.64 | 0.65 | |
| 33 (23–44) grade 1; 25 (19–35) grade 2; 14 (8–21) grade 3 | 61 (31–81) | 0.48 (0.06–0.73) | 0.49 (0.08–0.74) | 26 (grade 1) | 41 (grade 1) | 63 | 71 | 0.63 | 0.59 | 0.51 | 0.62 | |
| 24 (21–25) grade 1; 29 (25–33) grade 2; | 92 (88–100) | 0.90 (0.83–1) | 0.90 (0.83–1) | 24 (grade 1) | 24 (grade 1) | 91 | 91 | 0.87 | 0.89 | 0.88 | 0.89 | |
| 37 (29–44) grade 1; 28 (23–37) grade 2; 21 (4–23) grade 3 | 73 (41–88) | 0.63 (0.24–0.83) | 0.65 (0.22–0.83) | 37 (grade 1) | 38 (grade 1) | 67 | 70 | 0.54 | 0.58 | 0.55 | 0.60 | |
PABAK, prevalence-adjusted bias-adjusted kappa.
Intraobserver and interobserver results of the static, web-based, exercise on the midfoot joints (strength of agreement: <0.20 poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, 0.81–1.00 excellent)
| Intraobserver agreement of the static exercise_midfoot | Interobserver agreement of the static exercise_midfoot | |||||||||||
| Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean | Prevalence mean | Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean | Kappa mean | PABAK mean | PABAK mean | |
| 54 (29–75) | 85 (75–100) | 0.70 (0–0.9) | 0.71 (0–0.87) | 55 | 54 | 76 | 86 | 0.52 | 0.72 | 0.52 | 0.72 | |
| 53 (44–66) | 82 (29–100) | 0.65 (−0.42 to 1) | 0.65 (−0.42 to 1) | 57 | 50 | 79 | 85 | 0.58 | 0.70 | 0.58 | 0.70 | |
| 30 (13–41) grade 1; 20 (13–31) grade 2; 17 (7–25) grade 3 | 65 (14–94) | 0.54 (−0.06 to 0.91) | 0.54 (−0.14 to 0.91) | 23 (grade1) | 37 (grade 1) | 63 | 78 | 0.51 | 0.68 | 0.51 | 0.70 | |
| 51 (50–67) grade 1; 30 (25–38) grade 2; 18 (0–25) grade 3 | 91 (75–100) | 0.85 (0.6–1) | 0.88 (0.66–1) | 50 (grade 1) | 51 (grade 1) | 90 | 89 | 0.84 | 0.83 | 0.86 | 0.85 | |
| 38 (28–44) grade 1; 29 (16–44) grade 2; 17 (6–34) grade 3 | 71 (31–94) | 0.60 (0.12–0.91) | 0.61 (0.08–0.91) | 38 (grade 1) 26 (grade 2) 16 (grade 3) | 37 (grade 1) | 60 | 69 | 0.46 | 0.59 | 0.47 | 0.59 | |
PABAK, prevalence-adjusted bias-adjusted kappa.
Intraobserver and interobserver results of the static, web-based, exercise on the MTP joints (strength of agreement: <0.20 poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, 0.81–1.00 excellent)
| Intraobserver agreement of the static exercise_MTP | Interobserver agreement of the static exercise_MTP | |||||||||||
| Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean | Prevalence mean | Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean | Kappa mean | PABAK mean | PABAK mean | |
| 64 (45–80) | 82 (52–94) | 0.61 (0.03–0.87) | 0.63 (0.05–0.87) | 61 | 68 | 75 | 81 | 0.49 | 0.58 | 0.51 | 0.57 | |
| 63 (47–77) | 84 (30–100) | 0.67 (−0.35 to 1) | 0.68 (−0.39 to 1) | 65 | 61 | 81 | 78 | 0.61 | 0.56 | 0.63 | 0.57 | |
| 63 (46–79) | 84 (64–100) | 0.64 (0.22–1) | 0.68 (0.28–1) | 65 | 63 | 82 | 83 | 0.60 | 0.63 | 0.64 | 0.65 | |
| 35 (28–45) grade 1; 28 (20–38) grade 2; 12 (5–21) grade 3 | 60 (52–94) | 0.60 (0.19–0.79) | 0.46 (0.05–0.87) | 27 (grade 1) | 44 (grade 1) | 63 | 68 | 0.51 | 0.53 | 0.51 | 0.57 | |
| 19 (15–20) grade 1; 29 (25–35) grade 2; 21 (20–25) grade 3 | 93 (85–100) | 0.90 (0.79–1) | 0.90 (0.8–1) | 19 (grade 1) | 19 (grade 1) | 91 | 92 | 0.88 | 0.89 | 0.88 | 0.89 | |
| 38 (19–44) grade 1; 28 (18–38) grade 2; 9 (0–25) grade 3 | 78 (50–100) | 0.70 (0.33–1) | 0.71 (0.33–1) | 34 (grade 1) | 41 (grade 1) | 79 | 83 | 0.70 | 0.69 | 0.72 | 0.62 | |
MTP, metatarsophalangeal; PABAK, prevalence-adjusted bias-adjusted kappa.
Intraobserver and interobserver results of the live, patient-based, exercise considering together results of midfoot and MTP joints (strength of agreement: <0.20 poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, 0.81–1.00 excellent)
| Intraobserver agreement of the live exercise | Interobserver agreement of the live exercise | |||||||||||
| Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean | Prevalence mean | Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean | Kappa mean | PABAK mean | PABAK mean | |
| 17 (9–26) | 89 (70–97) | 0.64 (0.10–0.85) | 0.78 (0.40–0.94) | 17 | 18 | 85 | 85 | 0.46 | 0.51 | 0.70 | 0.70 | |
| 15 (7–25) | 91 (81–98) | 0.62 (0.10–0.94) | 0.81 (0.63–0.98) | 16 | 14 | 85 | 87 | 0.40 | 0.43 | 0.69 | 0.73 | |
| 88 (46–100) | 89 (75–100) | 0.5 (−0.12 to 1) | 0.79 (0.5–1) | 88 | 89 | 81 | 82 | 0.11 | 0.08 | 0.61 | 0.65 | |
| 12 (5–21) grade 1; 7 (1–12) grade 2; 1 (0–3) grade 3 | 85 (68–95) | 0.64 (0.13–0.80) | 0.78 (0.58–0.94) | 12 (grade 1) | 11 (grade 1) | 78 | 79 | 0.37 | 0.37 | 0.71 | 0.73 | |
| 3 (1–12) grade 1; 1 (0–3) grade 2; | 96 (89–99) | 0.41 (−0.01 to 0.79) | 0.95 (0.86–0.98) | 3 (grade 1) | 3 (grade 1) | 94 | 94 | 0.21 | 0.18 | 0.93 | 0.93 | |
| 36 (17–66) grade 1; 10 (3–25) grade 2; 2 (0–8) grade 3 | 72 (59–90) | 0.46 (0.21–0.78) | 0.62 (0.45–0.86) | 36 (grade 1) | 36 (grade 1) | 53 | 52 | 0.19 | 0.21 | 0.36 | 0.36 | |
MTP, metatarsophalangeal; PABAK, prevalence-adjusted bias-adjusted kappa.
Intraobserver and interobserver results of the live, patient-based, exercise on the midfoot joints (strength of agreement: <0.20 poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, 0.81–1.00 excellent)
| Intraobserver agreement of the live exercise_midfoot | Interobserver agreement of the live exercise_midfoot | |||||||||||
| Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean | Prevalence mean | Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean | Kappa mean | PABAK mean | PABAK mean | |
| 11 (3–18) | 90 (72–99) | 0.49 (0.08–0.79) | 0.80 (0.43–0.97) | 11 | 11 | 87 | 85 | 0.32 | 0.29 | 0.75 | 0.71 | |
| 9 (4–18) | 92 (83–100) | 0.57 (0.17–1) | 0.85 (0.66–1) | 10 | 9 | 88 | 89 | 0.30 | 0.34 | 0.76 | 0.79 | |
| 8 (6–21) grade 1; 3 (1–7) grade 2; 1 (0–3) grade 3 | 88 (72–99) | 0.48 (0.09–0.80) | 0.56 (0.43–0.98) | 9 (grade 1) | 7 (grade 1) | 82 | 82 | 0.24 | 0.23 | 0.76 | 0.77 | |
| 2 (0–6) grade 1; 1 (0–2) grade 2; | 97 (91–100) | 0.32 (−0.02 to 0.79) | 0.96 (0.87–1.0) | 2 (grade 1) | 2 (grade 1) | 97 | 96 | 0.22 | 0.13 | 0.95 | 0.95 | |
| 3 (14–70) grade 1; 7 (2–23) grade 2; 1 (0–5) grade 3 | 73 (58–89) | 0.43 (0.22–0.75) | 0.64 (0.43–0.85) | 34 (grade 1) | 34 (grade 1) | 54 | 52 | 0.18 | 0.17 | 0.38 | 0.37 | |
PABAK, prevalence-adjusted bias-adjusted kappa.